Subscribe To
: axsome’s stock falls after disclosing teva’s plans to market generic auvelity
Shares of Axsome Therapeutics Inc. AXSM tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva
February 13, 2023, 1:01 pm
First wave biopharma chairman and ceo issues letter to stockholders
BOCA RATON, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a c...
February 13, 2023, 12:00 pm
Polyphenol market worth usd 3.0 billion by 2030, to grow at a cagr of 5.20% – report by market research future (mrfr)
Polyphenol Market Insights and Industry Analysis by Source (Fruits, Vegetables, Whole Grains, Beverages), Type (Flavonoids, Phenolic Acids, Stilbenes,...
February 13, 2023, 10:49 am
Axsome therapeutics (axsm) stock falls as teva pursues generic depression drug
Axsome Therapeutics (NASDAQ: AXSM ) stock is taking a beating on Monday as rival Teva pharmaceutical (N...
February 13, 2023, 10:34 am
Don't buy viatris and organon just because of the dividends
Viatris and Organon are what can currently be described as "deep value plays" in the pharmaceutical sec...
February 13, 2023, 9:27 am
There's a lot to love about mineralys' valentine's day ipo
It has been less than a year since Mineralys Therapeutics (NASDAQ: MLYS) listed its IPO, but the activity has been quite hot, particularly since the t...
February 13, 2023, 9:23 am
Why is sorrento therapeutics (srne) stock down 40% today?
Sorrento Therapeutics (NASDAQ: SRNE ) stock is falling on Monday after the company filed for bankruptcy alongside subsidiary Scintilla ...
February 13, 2023, 9:17 am
Why is vallon pharmaceuticals (vlon) stock up 38% today
Vallon pharmaceuticals (NASDAQ: VLON ) stock is rising higher on Monday despite a lack of news from the...
February 13, 2023, 8:22 am
Fusion pharmaceuticals to present at the svb securities global biopharma conference
HAMILTON, ON and BOSTON , Feb. 13, 2023 /PRNewswire/ -- Fusion pharmaceuticals Inc. (Nasdaq: FUSN), a c...
February 13, 2023, 8:05 am
Tonix pharmaceuticals obtains exclusive license to develop fully human and murine anti-sars-cov-2 monoclonal antibodies
Tonix pharmaceuticals (NASDAQ:TNXP) Holding Corp. said it has exercised an option to obtain an exclusiv...
February 13, 2023, 8:01 am
Axsome's stock falls after disclosing teva's plans to market generic auvelity
Shares of Axsome Therapeutics Inc. AXSM, -0.27% tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that ...
February 13, 2023, 8:01 am
Marinus pharmaceuticals to provide business update and report fourth quarter 2022 financial results on march 7, 2023
RADNOR, Pa.--(BUSINESS WIRE)--Marinus pharmaceuticals, Inc. (Nasdaq: MRNS), a ...
February 13, 2023, 7:15 am
Polarean imaging looking to gain commercial traction for its xenoview
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) is looking to gain "commercial traction" for its medical imaging product, XENOVIEW, the first and only FDA-...
February 13, 2023, 2:57 am
pharmaceutical packaging market is expected to grow from usd 101.1 billion in 2023 to usd 206.6 billion by 2033: future market insights, inc.
Rising Demand for pharmaceutical Drugs and Innovations in Medicinal Packaging to Drive ...
February 13, 2023, 12:30 am
Aeon biopharma confirms development strategy and timelines for abp-450 unaffected by korean court ruling on dispute between medytox and daewoong pharmaceutical
IRVINE, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”), a clinical-stage bio...
February 11, 2023, 3:24 am
Fortress biotech announces closing of $13.9 million registered direct offering priced at-the-market under nasdaq rules
MIAMI, Feb. 10, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative bio...
February 10, 2023, 5:50 pm
Crinetics pharmaceuticals to participate in the svb securities global biopharma conference
SAN DIEGO, Feb. 10, 2023 (GLOBE NEWSWIRE) — Crinetics pharmaceuticals (Nasdaq: CRNX) today announced ...
February 10, 2023, 1:01 pm
Vyne therapeutics announces reverse stock split
Common stock expected to begin trading on split-adjusted basis on February 13, 2023 BRIDGEWATER, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) — VYNE Therape...
February 10, 2023, 1:00 pm
Aligos therapeutics to present at the svb securities global biopharma conference
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage bio...
February 10, 2023, 12:00 pm
Ayala pharmaceuticals reports financial results for the fiscal year ended october 31, 2022
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) — Ayala pharmaceuticals, ...
February 10, 2023, 12:00 pm